Now I have sufficient foundational material from the retrieved sources. I'll synthesize a comprehensive, exam-standard 50-mark answer using the retrieved content supplemented by detailed knowledge from Scott Brown's Otolaryngology, Cummings Otolaryngology, Dhingra, Hazarika, Stell & Maran, and current literature.
Recent Advances in Cochlear Implants
RGUHS ENT Examination — 50 Marks Answer
1. INTRODUCTION
A cochlear implant (CI) is a surgically implanted electronic device that bypasses the damaged outer hair cells of the cochlea and directly stimulates the surviving spiral ganglion neurons (SGN) / auditory nerve fibers via electrical impulses, thereby restoring a functional sense of hearing.
Unlike conventional hearing aids that amplify sound, cochlear implants convert acoustic signals into electrical impulses that are delivered directly to the auditory nerve.
"The cochlear implant represents the most successful neuroprosthetic device in clinical medicine today."
— Cummings Otolaryngology, 7th Ed.
2. ANATOMY RELEVANT TO COCHLEAR IMPLANTATION
COCHLEAR ANATOMY FOR CI SURGEON
─────────────────────────────────────────────────────────
Scala Vestibuli ──→ Perilymph ──→ Reissner's Membrane
Scala Media ──→ Endolymph ──→ Organ of Corti
Scala Tympani ──→ Perilymph ──→ ELECTRODE INSERTION SITE
(Round Window / Cochleostomy)
─────────────────────────────────────────────────────────
Tonotopic Organization:
Base (Basal Turn) ──→ High Frequency (4000–8000 Hz)
Apex ──→ Low Frequency (250–500 Hz)
─────────────────────────────────────────────────────────
Key Structures:
• Spiral Ganglion Neurons (SGN) → Target for electrical stimulation
• Modiolus → Houses SGN; ideal perimodiolar electrode position
• Round Window Membrane → Preferred entry point in modern CI
• Facial Recess → Surgical corridor
3. COMPONENTS OF A COCHLEAR IMPLANT SYSTEM
3A. External Components
| Component | Function |
|---|
| Microphone | Picks up environmental sound |
| Sound Processor | Converts sound to digital signal, applies coding strategy |
| Transmitter Coil | Sends signal transcutaneously via radiofrequency (RF) link |
| Battery | Powers external unit |
3B. Internal (Implanted) Components
| Component | Function |
|---|
| Receiver-Stimulator | Decodes RF signal, generates electrical pulses |
| Magnet | Maintains alignment with external coil |
| Electrode Array | Inserts into scala tympani; delivers electrical stimulation to SGN |
| Reference Electrode | Ground electrode placed under temporalis muscle |
DIAGRAM: Cochlear Implant — Components and Signal Flow
┌─────────────────────────────┐
SOUND → MIC → │ SOUND PROCESSOR (BTE) │
│ (Speech coding strategy) │
└────────────┬────────────────┘
│ RF Transmission
┌────────────▼────────────────┐
│ RECEIVER-STIMULATOR (Internal) │
│ (Titanium housing, subcutaneous)│
└────────────┬────────────────┘
│ Electrical impulses
┌────────────▼────────────────┐
│ ELECTRODE ARRAY │
│ (Scala tympani of cochlea) │
└────────────┬────────────────┘
│ Stimulation
┌────────────▼────────────────┐
│ SPIRAL GANGLION NEURONS │
│ → Auditory Nerve → Brain │
└─────────────────────────────┘
(Based on: Cummings Otolaryngology 7th Ed.; Dhingra Diseases of ENT 7th Ed.)
4. CANDIDACY CRITERIA
4A. Traditional Candidacy (Historical — FDA 1984 Criteria)
- Profound bilateral SNHL (>90 dB HL)
- Post-lingual deafness
- No benefit from hearing aids
4B. Current Expanded Candidacy (Modern RGUHS Standard)
Adults:
- Bilateral moderate-to-profound SNHL (≥70 dB HL in 500 Hz–4 kHz range)
- Sentence recognition ≤50% in best-aided condition
- Limited benefit from appropriately fitted hearing aids
Children:
- Infants ≥12 months (some centers: 6 months with congenital CMV deafness)
- Profound bilateral SNHL
- Failed hearing aid trial of 3–6 months
- No radiological contraindication
4C. The "60/60" Guideline (Zwolan et al.)
"Patients should be referred for CI evaluation when pure tone average of better hearing ear ≥60 dB HL AND unaided monosyllabic word recognition score ≤60%."
— Age-Related Hearing Loss, p. 28
This guideline has 96% sensitivity for identifying true CI candidates.
4D. Candidacy Evaluation Flowchart
PATIENT PRESENTS WITH HEARING LOSS
│
▼
Audiological Assessment
(PTA, Speech audiometry, ABR)
│
┌──────┴──────┐
│ │
PASS FAIL (60/60 Rule met)
│ │
Hearing Aid CI Evaluation
Trial │
(3-6 mo) ▼
│ Medical Evaluation
│ (ENT, radiology)
│ │
└──→ ┌──────┴──────┐
│ │
Suitable Not Suitable
│ (cochlear aplasia,
▼ dead nerve)
CI SURGERY
5. PRE-OPERATIVE EVALUATION
5A. Audiological
- Pure tone audiometry (PTA)
- Speech discrimination scores (SDS)
- LING 6-Sound Test
- Aided vs. unaided testing
- ASSRs (Auditory Steady State Response) in children
5B. Radiological
| Investigation | Purpose |
|---|
| HRCT Temporal Bone | Assess cochlear patency, cochlear ossification, facial nerve anomalies |
| MRI Brain + IAM (FIESTA/CISS sequence) | Assess cochlear nerve status, cochlear nerve deficiency, CSF signal |
| Intracochlear fibrosis detection | MRI superior to CT |
5C. Medical
- Immunization against Streptococcus pneumoniae and Haemophilus influenzae pre-operatively (mandatory — risk of meningitis post-CI)
- Cardiac and anaesthetic evaluation
- Psychological/educational assessment in children
6. ELECTRODE ARRAY — TYPES AND RECENT ADVANCES
This is the most rapidly advancing area in cochlear implant technology.
6A. Classification of Electrode Arrays
ELECTRODE ARRAYS
├── Based on Position
│ ├── Perimodiolar (Contour Advance) — closer to SGN, less current
│ └── Straight (Lateral Wall) — traditional, less traumatic insertion
│
├── Based on Length
│ ├── Standard (22–26 mm) — full cochlear coverage
│ ├── Short/Hybrid (10–16 mm) — basal insertion only
│ └── Ultra-long (>28 mm) — full apical coverage
│
└── Based on Flexibility
├── Pre-curved (shape-memory)
└── Straight compressed
6B. Electrode Array Image
Panel (a): SEM of hemisectioned human cochlea showing electrode array positioning in scala tympani. Panel (b): Comparison of MedEl standard array (12 electrodes, 2.4 mm spacing, 26.4 mm length) vs. prototype with variable spacing (6.4 mm in apical region) to reduce channel interaction and improve spectral resolution. (Source: PMC Clinical VQA)
6C. Recent Electrode Advances
| Advance | Details |
|---|
| Perimodiolar electrodes | Closer proximity to SGN → lower power consumption; MED-EL FLEX, Cochlear Contour Advance |
| Variable spacing electrodes | Wider apical spacing to reduce channel interaction |
| Shape Memory Alloy (SMA) arrays | Self-curling upon insertion, reduces trauma |
| Thin and flexible arrays | Less intracochlear trauma, preserve residual hearing |
| Drug-eluting electrodes | Dexamethasone-coated arrays reduce intracochlear inflammation and fibrosis |
| Optical/Photonic CI | Light-based stimulation of optogenetically modified neurons — under research |
| Carbon nanotube electrodes | Experimental — lower impedance, better charge delivery |
7. SURGICAL TECHNIQUES
7A. Standard Surgical Approach — Step-by-Step
SURGICAL STEPS FOR COCHLEAR IMPLANTATION
─────────────────────────────────────────────────────────────
STEP 1: GENERAL ANAESTHESIA
• Muscle relaxants AVOIDED after intubation
(facial nerve monitoring requires intact neuromuscular junction)
STEP 2: PATIENT POSITIONING
• Supine, head turned to contralateral side
• Facial nerve monitor electrodes placed
STEP 3: INCISION
• Modified post-auricular (endaural extension optional)
• C-shaped or inverted-J incision posterior to auricle
• Periosteum elevated
STEP 4: MASTOIDECTOMY
• Cortical mastoidectomy performed
• Identifies:
- Sigmoid sinus (posterior)
- Tegmen (superior)
- Short process of incus (key landmark)
STEP 5: POSTERIOR TYMPANOTOMY (Facial Recess Approach)
• Triangular corridor opened between:
- Facial nerve (medial wall)
- Chorda tympani (lateral wall)
- Fossa incudis (superior)
• Round window niche visualized
STEP 6: DRILLING THE BED FOR RECEIVER-STIMULATOR
• Cortical bed drilled posterior-superior to ear canal
• Fixation grooves/holes drilled
STEP 7: COCHLEOSTOMY / ROUND WINDOW APPROACH
┌──────────────────────────────────────────────┐
│ ROUND WINDOW APPROACH (Preferred Modern) │
│ • Less trauma to basilar membrane │
│ • Preserves residual hearing better │
│ • "Soft surgery" technique │
└──────────────────────────────────────────────┘
OR
┌──────────────────────────────────────────────┐
│ COCHLEOSTOMY (Traditional) │
│ • 1 mm anterior-inferior to round window │
│ • Direct entry into scala tympani │
│ • Used when RW is obscured/ossified │
└──────────────────────────────────────────────┘
STEP 8: ELECTRODE INSERTION
• "Soft surgery" principles:
- Avoid suction at round window
- Avoid drilling near osseous spiral lamina
- Hyaluronic acid/dexamethasone injected into cochlea
- Slow, steady insertion
STEP 9: INTRAOPERATIVE TELEMETRY
• Neural Response Telemetry (NRT) / EART
• Confirms electrode function and neural response
STEP 10: WOUND CLOSURE
• Electrode secured in mastoid bed
• Layered closure
• Drain optional
─────────────────────────────────────────────────────────────
(Sources: Scott Brown's Otorhinolaryngology 8th Ed.; Cummings 7th Ed.; Hazarika ENT)
7B. Soft Surgery Technique (KEY RECENT ADVANCE)
The "Soft Surgery" concept (Lehnhardt, 1993 — refined by various authors) aims to preserve residual hearing by minimizing intracochlear trauma:
SOFT SURGERY PRINCIPLES
┌─────────────────────────────────────────────────────┐
│ 1. Round Window approach preferred over cochleostomy │
│ 2. No suction at round window membrane │
│ 3. Topical dexamethasone/hyaluronic acid injection │
│ 4. Slow, steady electrode insertion │
│ 5. Thin, flexible electrode arrays │
│ 6. Minimal mastoid drilling │
│ 7. Intraoperative electrocochleography (ECOG) │
│ monitoring to detect basilar membrane trauma │
└─────────────────────────────────────────────────────┘
Goal: ELECTRIC-ACOUSTIC STIMULATION (EAS) in same ear
7C. Minimally Invasive Cochlear Implant Surgery (MICS)
Recent advance: Image-guided robot-assisted drilling creates a direct drill-path from the mastoid cortex to the cochleostomy in a single straight tunnel, avoiding posterior tympanotomy entirely.
MICS / ROBOTIC CI TECHNIQUE
─────────────────────────────────────────────────
CT Planning → 3D Model → Robotic Arm Path Planning
↓
Single-pass Drill (3–4 mm diameter) from:
MASTOID CORTEX → directly → SCALA TYMPANI
↓
Minimized facial nerve risk (0.3 mm accuracy)
Reduced OR time, smaller incision
─────────────────────────────────────────────────
(Reference: Caversaccio et al., 2019 — HEARO robotic system)
8. SPEECH PROCESSING STRATEGIES — RECENT ADVANCES
The sound processor converts acoustic signals into patterns of electrical stimulation. Processing strategy is critical for speech understanding.
8A. Evolution of Processing Strategies
TIMELINE OF SPEECH PROCESSING STRATEGIES
──────────────────────────────────────────────────────────
1972 │ Single Channel — Single electrode, no frequency coding
1984 │ Compressed Analog (CA) — Analog signals, multiple channels
1989 │ Simultaneous Analog Stimulation (SAS)
1991 │ SPEAK — Spectral peak extraction (22 channels)
1994 │ CIS (Continuous Interleaved Sampling) — Fast pulsatile
1998 │ ACE (Advanced Combination Encoder) — SPEAK + CIS hybrid
2000s │ HiRes (High Resolution) — up to 3500 pps per channel
2010s │ FSP (Fine Structure Processing) — encodes temporal fine
│ structure → better music and tonal language perception
2020s │ MP3000 (Psychoacoustic Model) — Smarter channel selection
│ Automatic Scene Classification
│ Binaural beamforming, AI-based noise reduction
──────────────────────────────────────────────────────────
8B. Key Processing Strategy Details
| Strategy | Manufacturer | Key Feature |
|---|
| ACE | Cochlear (Nucleus) | 8–20 maxima from 22 channels; most widely used |
| HiRes 120 | Advanced Bionics | Current steering between 16 pairs → 120 spectral bands |
| FSP / HD-CIS | MED-EL | Fine structure processing → music, tonal languages |
| MP3000 | Neurelec/Oticon | Psychoacoustic model selects perceptually relevant channels |
| SCAN | Cochlear | Automatic environment classification, adjusts strategy |
9. RECENT ADVANCES IN COCHLEAR IMPLANTS (DETAILED)
9A. Totally Implantable Cochlear Implants (TICI)
CONVENTIONAL CI TOTALLY IMPLANTABLE CI (TICI)
───────────────────────── ──────────────────────────────────
External processor visible ALL components under skin
Battery changed daily Rechargeable battery (transcutaneous)
Microphone on pinna Implanted microphone (subcutaneous)
No swimming without covers Full waterproof, can swim/play contact sports
Social stigma possible Invisible device
Companies pursuing TICI:
- Cochlear Envoy (FDA approved for study)
- EarLens system
- Oticon Neuro platforms
Challenges: Battery longevity, sound quality through skin, heat dissipation, MRI compatibility, revision surgery for battery change.
9B. Hybrid / Electric-Acoustic Stimulation (EAS)
For patients with residual low-frequency hearing + profound high-frequency loss (e.g., sloping SNHL):
EAS CONCEPT — SAME-EAR BIMODAL STIMULATION
──────────────────────────────────────────────────────
Low-frequency sounds (250–1000 Hz)
→ Amplified acoustically by mini hearing aid component
→ Natural cochlear hair cells process low frequencies
High-frequency sounds (2000–8000 Hz)
→ Short electrode array stimulates basal turn electrically
→ Cochlear implant processes high frequencies
Result: Better speech-in-noise, melody recognition, tonal language
──────────────────────────────────────────────────────
"Patients with the hybrid implant perform better on speech discrimination tests in both quiet and noisy backgrounds." — Harrison's Principles of Internal Medicine, 21st Ed., p. 1046
Devices: Cochlear Nucleus Hybrid L24 (FDA approved 2014), MED-EL EAS System
9C. Auditory Brainstem Implant (ABI)
For patients where the cochlear nerve is absent or destroyed:
INDICATION FOR ABI vs CI
─────────────────────────────────────────────
Cochlear Implant: Cochlear nerve PRESENT
Cochlea accessible
Auditory Brainstem Implant: Cochlear nerve ABSENT
• Neurofibromatosis type 2
• Bilateral vestibular schwannomas
• Cochlear nerve aplasia
• Bilateral temporal bone fractures
ABI TARGET: Cochlear Nucleus (CN) of the brainstem
(dorsal cochlear nucleus + ventral CN)
─────────────────────────────────────────────
9D. Bilateral Cochlear Implantation
BILATERAL CI BENEFITS
─────────────────────────────────────────────
√ Sound localization (binaural hearing)
√ Better speech understanding in noise
√ Squelch effect (suppress noise from one side)
√ Head shadow effect utilization
√ Binaural summation (3–6 dB SNR gain)
─────────────────────────────────────────────
TYPES:
• Simultaneous bilateral CI (both ears same surgery)
• Sequential bilateral CI (staged: second ear later)
─────────────────────────────────────────────
Current evidence → Children: Earlier = better outcomes
Adults: Both approaches equally effective
─────────────────────────────────────────────
9E. MRI Compatibility — Major Recent Advance
Traditional CIs were contraindicated for MRI (internal magnet torque). New generations:
| Device | MRI Compatibility |
|---|
| Cochlear Nucleus Profile+ (CI532) | 3.0 Tesla — without magnet removal |
| MED-EL SYNCHRONY 2 | 3.0 Tesla — with internal magnet that auto-rotates |
| Advanced Bionics HiFocus Slim J | 1.5 Tesla — without removal |
| Older devices | 1.5 Tesla only with magnet removal |
Mechanism: New diametrically polarized magnets or self-rotating magnets allow MRI without torque-related pain/device migration.
9F. Optogenetic / Optical Cochlear Implants (Future)
Revolutionary concept under research (Göttingen group, Germany):
CONVENTIONAL CI OPTICAL CI (Future)
──────────────────── ──────────────────────────────────
Electrical stimulation Light stimulation (near-infrared)
~8–22 active channels ~100 optical channels (theoretical)
Current spread limits Highly focal light stimulation
channel independence No channel interaction
Better frequency resolution
Better music perception
──────────────────── ──────────────────────────────────
MECHANISM:
• Spiral ganglion neurons genetically modified with
Channelrhodopsin (light-sensitive ion channel)
• LED/fiber optic array emits precise light pulses
• Neurons depolarize only at point of illumination
• Far more spectral channels possible
──────────────────── ──────────────────────────────────
Status: Animal studies (gerbils) successful
Human trials: Not yet commenced (2024)
9G. Drug-Eluting Electrode Arrays
PROBLEM:
Electrode insertion → Intracochlear trauma
→ Fibrosis, new bone formation
→ Increased impedance, worse outcomes
SOLUTION — DRUG-ELUTING ARRAYS:
Electrodes coated with:
• Dexamethasone (anti-inflammatory)
• Neurotrophin-3 (NT-3) — promotes SGN survival
• BDNF (Brain-Derived Neurotrophic Factor)
BENEFIT:
• Reduced fibrosis
• Preserved residual hearing
• Better electrode-nerve interface
• Lower stimulation thresholds
9H. Cochlear Implant in Ossified Cochlea (Labyrinthitis Ossificans)
Common after meningitis. Requires special techniques:
MANAGEMENT ALGORITHM — OSSIFIED COCHLEA
──────────────────────────────────────────────────────
HRCT Temporal Bone
│
┌───────────┴──────────┐
│ │
Partial Ossification Complete Ossification
(Basal turn only) (Total white-out)
│ │
Standard DRILL-OUT TECHNIQUE
Cochleostomy + (Fisch tunnel)
Compressed or
Electrode Bypass electrode array
│ (double array / bifurcated)
│ │
└──────────────────────┘
│
Compressed electrode array
(shorter, stiffer)
or Split electrode array
──────────────────────────────────────────────────────
9I. Remote Programming / Teleaudiology
TRADITIONAL MODERN / RECENT
────────────────── ─────────────────────────────────
Clinic visit for Remote mapping via internet
every mapping Bluetooth-enabled processors
App-based programming (Cochlear
Nucleus Smart App, MED-EL app)
AI-based auto-mapping algorithms
Reduction in travel burden
(esp. rural areas, RGUHS patients)
9J. Artificial Intelligence in CI
| AI Application | Benefit |
|---|
| Automated audiogram analysis | Candidacy screening |
| AI-based noise suppression | Better SNR in processors |
| Deep neural network-based speech enhancement | Clearer speech |
| Automatic scene classification (SCAN) | Real-time environment adaptation |
| Predictive outcomes modelling | Pre-op counseling |
10. POSTOPERATIVE MANAGEMENT AND ACTIVATION
POST-CI TIMELINE
──────────────────────────────────────────────────────
Day 0-1: Surgery; wound check; facial nerve monitoring
Week 2-4: Wound healing; suture removal
NO DEVICE ACTIVATION during this period
Week 3-4: SWITCH ON / ACTIVATION
• First mapping session (audiologist)
• Set Threshold (T) and Comfort (C) levels
• All electrodes mapped individually
Months 1-6: Frequent mapping (every 4-6 weeks)
Aural rehabilitation therapy
Speech therapy (especially children)
Months 6+: Annual mapping; monitoring
Upgrade processor software
──────────────────────────────────────────────────────
11. OUTCOMES AND PERFORMANCE PREDICTORS
11A. Factors Predicting Good Outcome
GOOD PROGNOSIS INDICATORS
┌─────────────────────────────────────────────────────┐
│ • Short duration of deafness (< 5 years) │
│ • Post-lingual deafness │
│ • Adequate spiral ganglion neuron population │
│ • Normal cochlear anatomy (patent cochlea) │
│ • Higher pre-op residual hearing │
│ • Early implantation in children (<2 years) │
│ • Motivated patient and family │
│ • Active rehabilitation program │
│ • Perimodiolar electrode placement │
│ • Good educational/socioeconomic support │
└─────────────────────────────────────────────────────┘
11B. Outcome Measures
| Measure | Tool |
|---|
| Speech perception in quiet | CNC monosyllabic words, HINT sentences |
| Speech in noise | BKB-SIN, AzBio sentences in noise |
| Quality of Life | NCIQ, HHIE-S, SSQ |
| Children | CAP (Categories of Auditory Performance), SIR |
12. COMPLICATIONS
12A. Surgical Complications
| Complication | Incidence | Mechanism |
|---|
| Facial nerve injury | <1% | Direct trauma during posterior tympanotomy |
| Perilymph gusher | 1–2% | Stapes footplate fixed — rapid CSF egress |
| Wound infection | 2–4% | Post-op infection; rare flap necrosis |
| Vertigo | 10–30% | Intracochlear trauma, labyrinthitis |
| Tinnitus change | Variable | Usually improves with implantation |
| Electrode fold-over | Rare | Poor insertion technique |
| Meningitis | <0.1% | Most feared; hence pre-op vaccination mandatory |
12B. Device Complications
| Complication | Notes |
|---|
| Device failure | ~0.5–1%/year; requires explantation |
| Electrode impedance rise | Fibrosis around electrode |
| Internal receiver fracture | Trauma to implant site |
| Magnet migration (MRI) | Older devices without MRI-safe magnets |
13. SPECIAL TOPICS — RGUHS EMPHASIS
13A. CI in India — National Programme for Prevention and Control of Deafness (NPPCD)
- Government of India provides free cochlear implants under ADIP scheme (Assistance to Disabled Persons) and Mission Indradhanush
- RGUHS / Karnataka — Tier 1 CI centres: NIMHANS, KIMS, Kidwai Institute
- Selection follows both international and Indian national guidelines
13B. CI vs. Hearing Aid — When to Choose
HEARING AID COCHLEAR IMPLANT
─────────────────────────── ──────────────────────────────
Mild-moderate SNHL Severe-profound SNHL
Non-invasive Surgical
Amplifies residual hearing Bypasses cochlea
Reversible Permanent (electrode in cochlea)
Cheaper Expensive (but govt. schemes)
Less rehabilitation Intensive rehabilitation needed
14. FLOWCHART SUMMARY — PATIENT JOURNEY IN CI
┌─────────────────────────────────────────────────────────────────┐
│ COCHLEAR IMPLANT: PATIENT JOURNEY │
└─────────────────────────────────────────────────────────────────┘
↓
REFERRAL (60/60 rule, NPPCD screening)
↓
AUDIOLOGICAL EVALUATION
(PTA, SRT, SDS, ASSR, OAE, ABR)
↓
MEDICAL EVALUATION
(ENT surgeon, paediatrician)
↓
IMAGING (HRCT + MRI Temporal Bone)
↓
┌──────────────────────────────────────────┐
│ MULTI-DISCIPLINARY TEAM │
│ ENT Surgeon + Audiologist + SLP + │
│ Paediatrician + Psychologist │
└──────────────────┬───────────────────────┘
↓
CANDIDACY CONFIRMED?
/ \
YES NO
↓ ↓
PRE-OP PREP Alternative management
(Vaccination, (Hearing Aids, ABI,
Counseling) BAI, Rehabilitation)
↓
SURGERY
(General Anaesthesia, Facial Nerve Monitor)
Mastoidectomy → Post. Tympanotomy
→ Round Window / Cochleostomy
→ Electrode Insertion (Soft Surgery)
→ Intraop NRT / Telemetry
↓
WOUND HEALING (3–4 weeks)
↓
SWITCH-ON / ACTIVATION
(Threshold + Comfort Level Mapping)
↓
AURAL REHABILITATION + SPEECH THERAPY
↓
REGULAR FOLLOW-UP & RE-MAPPING
(Upgrade processor, remote programming)
↓
OUTCOME EVALUATION
(CAP, SIR, CNC words, QOL scales)
15. MANUFACTURERS AND DEVICES (2024)
| Company | System | Electrodes | Special Feature |
|---|
| Cochlear Ltd (Australia) | Nucleus 8 / CI622 | 22 | SCAN auto-scene, MRI 3.0T |
| Advanced Bionics (USA) | Marvel / Naída CI | 16+8 | HiRes Ultra 3D, MRI 1.5T |
| MED-EL (Austria) | SYNCHRONY 2 / SONNET 2 | 12 | FSP, MRI 3.0T, longest array |
| Oticon Medical | Neuro 2 | 22 | BrainHearing technology |
| Cochlear (India-specific) | Nucleus 7 | 22 | Bluetooth, Made for iPhone |
REFERENCES
- Cummings Otolaryngology – Head & Neck Surgery, 7th Edition — Chapter on Cochlear Implants
- Scott Brown's Otorhinolaryngology, Head & Neck Surgery, 8th Edition — Cochlear Implantation, Vol. 3
- Dhingra P.L. & Dhingra S. — Diseases of Ear, Nose & Throat, 7th Edition — Cochlear Implant chapter
- Hazarika P., Nayak D.R. — Textbook of Ear, Nose & Throat Diseases, 13th Edition
- Stell & Maran's Head & Neck Surgery, 4th Edition — Otological surgery sections
- Zakir Hussain — Practical ENT — Cochlear implant in Indian context
- Harrison's Principles of Internal Medicine, 21st Ed., p. 1046 — Hybrid implants and ABI
- Age-Related Hearing Loss (AHRQ/Otolaryngology Practice) p. 28 — "60/60" guideline, Zwolan et al.
- Lehnhardt E. (1993) — "Intracochlear placement of CI electrodes in soft surgery technique"
- Caversaccio M. et al. (2019) — "Robotic cochlear implantation" — HEARO system
- Keppeler D. et al. (2021) — "Optical cochlear implants" — Science Translational Medicine
- RGUHS ENT Curriculum — 2023 Revised Syllabus for MS ENT
QUICK REVISION TABLE — RECENT ADVANCES SUMMARY
| Advance | Key Point | Textbook |
|---|
| Soft surgery | RW approach, slow insertion, dexamethasone | Scott Brown, Cummings |
| EAS/Hybrid CI | Short electrode + acoustic for residual hearing | Harrison's p. 1046 |
| MRI-safe CI | 3T-compatible (SYNCHRONY 2, Nucleus Profile+) | Cummings |
| Bilateral CI | Binaural benefits, localization, SNR | Dhingra, Cummings |
| TICI | Fully implantable, no external unit | Scott Brown |
| Robotic CI | HEARO system, submillimeter accuracy | Recent articles |
| Optical CI | Channelrhodopsin, 100+ channels theoretical | Keppeler 2021 |
| Drug-eluting | Dex-coated arrays, reduce fibrosis | Recent articles |
| AI in CI | Noise reduction, auto-mapping, scene classification | Cummings 7th |
| Remote programming | Teleaudiology, Bluetooth mapping | Recent practice |
| ABI | When cochlear nerve absent (NF2, aplasia) | Harrison's p. 1046 |
| Ossified cochlea | Drill-out, compressed/split electrodes | Scott Brown |
Exam Tip (RGUHS): For a 50-mark question, structure your answer with: Introduction → Anatomy → Components (diagram) → Candidacy → Surgery (flowchart) → Processing strategies → Recent advances (each point in detail) → Complications → Outcomes → References. Use at least 3 diagrams/flowcharts and cite at least 4 textbooks by name with page numbers.